ANRO

ALTO NEUROSCIENCE INC

ANRO·02157Q109·US·Common Stock·Healthcare - Biotechnology-13D/G

ANRO (ALTO NEUROSCIENCE INC) is held by 73 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($56M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($42.2M), VANGUARD CAPITAL MANAGEMENT LLC ($36.7M). Net institutional sentiment: Mixed.

73
Holders
(5 Elite)
$329.2M
Total Value
62% (76)
Consensus
47 buying - 29 selling
13F: Insider & Congress: Updated regularly
ANRO

Smart Money Verdict

View all
Loading verdict
Held by 73 funds
5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistVPVestal Point Capital, LP2.2%Aug 14, 2026
ActivistPAPerceptive Advisors LLC10.0%Aug 14, 2026
ActivistSISirenia Capital Management LP6.2%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.1M(+218.4%)$56M0.0%+70.60%
47
Increased
1.6M(+315.6%)$42.2M0.1%+46.83%
47
Increased
1.4M(+15.1%)$36.7M0.0%+74.50%
33
Decreased
1M(-8.0%)$26.7M0.0%+165.40%
0
Increased
685,945(+243.8%)$18.1M0.0%+59.53%
46
Increased
678,199(+131.6%)$17.9M0.0%+77.38%
46
Increased
632,701(+33.6%)$16.7M0.0%+203.30%
36
Decreased
558,320(-32.1%)$14.7M0.0%+192.98%
0
Decreased
502,950(-0.0%)$13.3M0.0%+220.08%
0
Increased
487,576(+0.2%)$12.9M0.1%+96.16%
28
New
257,631$6.8M0.0%+38.42%
38
Increased
236,830(+126.2%)$6.2M0.0%+92.72%
44
Increased
225,503(+27.9%)$6M0.0%+311.43%
34
Increased
211,257(+27.8%)$5.6M0.0%+70.09%
34
Increased
190,996(+1333.5%)$5M0.0%+44.05%
43
New
181,101$4.8M0.0%+38.42%
37
Decreased
147,299(-31.8%)$3.9M0.0%+218.60%
0
Decreased
102,101(-55.0%)$2.7M0.0%+241.72%
0
Decreased
85,480(-1.0%)$2.3M0.0%+774.22%
0
Increased
80,583(+373.5%)$2.1M0.0%+48.46%
42

Showing 1-20 of 85

1 / 5
ANROANROALTO NEUROSCIENCE INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used